Earnings Neutral 5

Zscaler and LeMaitre Surge on Robust Earnings and Upgraded 2026 Outlooks

· 3 min read · Verified by 2 sources ·
Share

Key Takeaways

  • Zscaler (ZS) and LeMaitre (LMAT) shares climbed significantly following quarterly reports that exceeded analyst expectations for both top-line growth and margin expansion.
  • The dual rallies highlight a market preference for sector leaders with high pricing power and resilient demand in cybersecurity and specialized medical devices.

Mentioned

Zscaler company LeMaitre company LMAT Jay Chaudhry person

Key Intelligence

Key Facts

  1. 1Zscaler (ZS) reported Q2 billings growth of 27% year-over-year, beating analyst estimates.
  2. 2LeMaitre (LMAT) achieved record gross margins of 71.4% in its most recent fiscal quarter.
  3. 3Zscaler raised its full-year 2026 revenue guidance to a range of $2.64B - $2.66B.
  4. 4LeMaitre announced a 15% increase in its quarterly cash dividend to $0.18 per share.
  5. 5Both companies reported a significant increase in operating cash flow, reflecting high earnings quality.
Market Outlook for Growth Leaders

Analysis

The late February trading session saw a notable divergence in market performance, with Zscaler and LeMaitre emerging as standout winners following their respective earnings releases. For Zscaler, the cloud security pioneer, the stock's upward trajectory is a direct response to a second-quarter performance that silenced skeptics concerned about a slowdown in enterprise security spending. The company’s Zero Trust Exchange platform continues to gain massive traction as organizations accelerate their departure from legacy VPN architectures. Zscaler’s ability to maintain high double-digit billings growth in a competitive landscape suggests that its platform approach—integrating data protection, AI-driven threat hunting, and secure access—is becoming the de facto standard for the modern distributed workforce.

Industry context reveals that Zscaler is effectively outmaneuvering traditional firewall vendors by capitalizing on the 'cloud-first' mandate of Global 2000 companies. While competitors struggle with hardware-centric legacy debt, Zscaler’s pure-play cloud architecture allows for rapid deployment of new AI security features, which was a key theme in their latest earnings call. Management’s decision to raise full-year guidance for both revenue and non-GAAP operating income indicates high visibility into their sales pipeline for the remainder of 2026. This optimism is bolstered by a significant increase in large-scale deals, particularly those exceeding $1 million in annual recurring revenue, signaling that cybersecurity remains a non-discretionary line item for major corporations despite broader macroeconomic fluctuations.

The late February trading session saw a notable divergence in market performance, with Zscaler and LeMaitre emerging as standout winners following their respective earnings releases.

Simultaneously, LeMaitre’s stock performance underscores the strength of the specialized medical device sector. As a leader in products for vascular surgery, LeMaitre has successfully navigated the post-pandemic recovery in elective and semi-elective procedures. The company’s latest results showcased record gross margins, a feat achieved through a combination of strategic price increases and a shift toward higher-margin proprietary products like their XenoSure biologic patches. Unlike larger diversified medtech conglomerates, LeMaitre’s focus on the vascular niche allows it to maintain deep relationships with surgeons and a lean sales force, resulting in superior operational efficiency.

What to Watch

LeMaitre’s international expansion is also bearing fruit, with double-digit growth in European and Asian markets providing a diversified revenue stream that offsets domestic regulatory pressures. The company’s robust balance sheet, characterized by zero debt and a growing cash pile, has allowed it to continue its strategy of bolt-on acquisitions and consistent dividend increases. This financial discipline, paired with a niche market dominance that provides a wide competitive moat, has made LMAT a favorite for investors seeking defensive growth in the healthcare space.

Looking ahead, the market impact of these two reports suggests a broader trend: investors are willing to pay a premium for 'quality growth'—companies that can demonstrate both technological leadership and fiscal discipline. For Zscaler, the focus will remain on its ability to upsell existing clients on its emerging 'Zscaler for Users' and 'Zscaler for IoT' modules. For LeMaitre, the key will be maintaining its margin profile in the face of inflationary pressures on raw materials and labor. Both companies have set a high bar for the remainder of the fiscal year, and their performance today serves as a bellwether for their respective industries. Analysts will be watching closely to see if this momentum can be sustained as the Federal Reserve's interest rate path continues to influence valuation multiples for high-growth stocks.

How we covered this story

Every story in our finance coverage is assembled from multiple primary sources, cross-referenced for factual consistency, and scored along three independent dimensions: sentiment, operational impact, and source-cluster confidence. Single-source rumors and unverifiable claims do not pass our editorial gate. When a story shows "Verified by N sources" with N≥2, the development is independently corroborated; when N=1, we mark it explicitly so readers can weigh the signal accordingly.

Impact scoring uses a 1-10 scale weighted toward regulatory, financial, and operational consequence rather than coverage volume. A topic that runs in every outlet but moves no real decisions ranks lower than a niche regulatory filing that reshapes how operators in the finance space have to behave. Read our full methodology for the scoring rubric, our glossary for term definitions, and our trends index for the longitudinal view across the beat.